ELIFE HLDGS (00223) appoints Li Ming as a non-executive director
ELIFE HLDGS (00223) announced that Ms. Li Ming has been appointed as a non-executive director, and Mr. Hua Hongji and Ms. Ding Xin have each been appointed as independent non-executive directors, all effective from November 10, 2026.
ELIFE HLDGS (00223) announced that Ms. Li Ming has been appointed as a non-executive director, and Mr. Hua Hongji and Ms. Ding Xin have each been appointed as independent non-executive directors, all with effect from November 10, 2026.
In addition, Mr. Hua Hongji has been appointed as a member of each of the Company's audit committee and remuneration committee; Ms. Ding Xin has been appointed as the chairman of the remuneration committee and a member of each of the audit committee and the Company's nomination committee; Mr. Feng Zhibin, the chairman of the board of directors, an executive director and an existing member of the nomination committee, has been appointed as the chairman of the nomination committee; Mr. Zhao Zhenzhong, the vice chairman of the board of directors, the chief executive officer and an executive director, has ceased to be a member of the nomination committee; Mr. Zhang Zhilin, an executive director, has been appointed as a member of the remuneration committee and has ceased to be a member of the nomination committee; and Mr. Hu Guocai, an independent non-executive director, has ceased to be a member of the remuneration committee.
In order to streamline and optimize the Company's corporate governance structure and decision-making process, and to allow the Company time to review and formulate its relevant policies and strategies and assess the future needs of the relevant committees, the investment and strategy committee has been dissolved with effect from November 10, 2026. Following the dissolution, the functions and responsibilities of the investment and strategy committee will be assumed by the board of directors.
Related Articles

LIANLIAN (02598) repurchased 58,000 shares on November 10 for approximately HK$179,100.

SUN HUNG KAI CO (00086) repurchased 9,000 shares for HK$35,200 on November 10.

EPIWORLD (02726) repurchased approximately 47,200 shares for about HK$3.8659 million on November 10.
LIANLIAN (02598) repurchased 58,000 shares on November 10 for approximately HK$179,100.

SUN HUNG KAI CO (00086) repurchased 9,000 shares for HK$35,200 on November 10.

EPIWORLD (02726) repurchased approximately 47,200 shares for about HK$3.8659 million on November 10.






